Viewing Study NCT06767956


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-02-17 @ 10:12 PM
Study NCT ID: NCT06767956
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-04
First Post: 2025-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy
Sponsor: Natalie Galanina
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module